Christopher S. Lynch insider trades: Tenet Healthcare (THC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | THC | ↓ Sell | 3,837 | $243.44 | $934K | Direct | Jul 28, 2026 (1d) |
| Aug 28, 2025 | THC | ↓ Sell | 8 | $183.44 | $1K | Direct | Aug 29, 2025 (1d) |
| Aug 19, 2025 | THC | ↓ Sell | 3,952 | $176.39 | $697K | Direct | Aug 21, 2025 (2d) |
| May 30, 2024 | THC | ↓ Sell | 10,861 | $133.83 | $1.5M | Direct | Jun 3, 2024 (4d) |
| Feb 15, 2024 | THC | ↓ Sell | 7,978 | $89.60 | $715K | Direct | Feb 16, 2024 (1d) |
| May 9, 2012 | AIG | ↑ Buy | 3,155 | $31.68 | $100K | Direct | May 10, 2012 (1d) |
| May 9, 2012 | AIG | ↑ Buy | 15 | $31.90 | $479 | By Child | May 10, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other THC insiders
Open-market trades in the last 12 months
About Christopher S. Lynch's insider trades
Christopher S. Lynch is an insider at Tenet Healthcare (THC). Since May 9, 2012, Christopher has reported 2 open-market purchases worth $100K and 5 sales worth $3.8M on SEC Form 4. In the last 12 months: 1 sale ($934K).
Their filings also include grants and awards (60 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every THC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.